SBIR/STTR Research Award
Plasmid-seeded aligned nanofibrillar scaffold for acute muscle injury treatment
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2015Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- Fibralign Corporation
- Proposal award date
- 2015-03-01
- Contract end date
- 2015-09-30
- UEI
- SKHKN4KZAE48
- Solicitation number
- 2014.1
- Topic code
- DHP14-009
Research abstract
Traumatic injury leading to hemorrhage damage and ischemia is a significant cause of morbidity and mortality in wounded warfighters. Particularly significant is the loss of the microvasculature. We propose to enhance and guide neovascularization using novel plasmid-activated scaffolds. Such scaffolds are formed of multi-lumenal threads made from aligned
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Aligned Nanofibrillar Scaffold Activated with HGF-mmRNA in Combination with Minced Muscle Graft for Treating Volumetric Muscle Loss (VML) Injury
- Prospective evaluation of a surgical solution for breast cancer-associated lymphedema
- Plasmid-seeded aligned nanofibrillar scaffold for acute muscle injury treatment
- Cell-Seeded Implant for Guided Lymphatic Regeneration
- SBIR Phase I: Nanofibrillar Scaffolds for Tissue Engineering
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Tissue Engineered Vascular Graft
- Biointegrated Synthetic Grafts for Reconstruction of Vascular Tissue
- Technologies That Reconstruct or Regenerate Vascular Tissue in the Extremities After Traumatic Injury
Research funding history
7 SBIR/STTR records share this UEI (2012–2019). Reported award amounts total $6,400,153. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Defense, Department of Health and Human Services, National Science Foundation